Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Inward rectifier potassium channel 4 (Kir2.3), encoded by the KCNJ4 gene, is a member of the inwardly rectifying potassium channel family that plays a vital role in stabilizing the resting membrane potential (UniProt: P48050). These channels preferentially allow potassium ions to flow into the cell, thereby controlling the excitability of neurons and cardiomyocytes (NCBI Gene: 3761). Kir2.3 is predominantly expressed in the central nervous system, specifically within the hippocampus and forebrain, where it often associates with PDZ-domain proteins to modulate synaptic transmission (PubMed: 10433262). In the heart, Kir2.3 contributes to the IK1 current, which is essential for the terminal repolarization phase of the action potential (PubMed: 11886830). Dysfunction of Kir2.3 has been linked to various pathological states, including cardiac arrhythmias and potential roles in neuropsychiatric conditions (PubMed: 25833132). While it is a recognized therapeutic target, the development of highly selective ligands remains a challenge in pharmacology, with current interactions limited to non-specific blockers like barium or multi-channel antiarrhythmics like flecainide (PubChem: CID 3356).
Inhibition of potassium efflux through the channel pore to modulate membrane potential and action potential duration.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inward rectifier potassium channel 4 (Kir2.3) (Kir2.3).